Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens

Anaerobe

Volumn 14, Issue 3, 2008, Pages 166-171

  Spinler, Jennifer K ^a,b   Taweechotipatr, Malai ^d   Rognerud, Cheryl L ^b   Ou, Ching N ^a,b   Tumwasorn, Somying ^c   Versalovic, James ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Antibiotics; Gastroenteritis; Lactic acid bacteria; Lactobacilli; Reuterin

Indexed keywords

3 HYDROXYPROPIONALDEHYDE; ANTIINFECTIVE AGENT; GLYCEROL; GLYCEROL DERIVATIVE; PROBIOTIC AGENT; REUTERIN;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; GASTROENTERITIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS REUTERI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SHIGELLA SONNEI; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

ANTIBIOSIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; FEMALE; GASTROENTERITIS; GLYCERALDEHYDE; GRAM-NEGATIVE BACTERIA; HUMANS; INTESTINES; LACTOBACILLUS REUTERI; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; PROPANE; SALMONELLA ENTERICA; SHIGELLA SONNEI; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOBACILLUS REUTERI; NEGIBACTERIA; POSIBACTERIA; SALMONELLA ENTERICA; SHIGELLA SONNEI; VIBRIO CHOLERAE;

EID: 44649149490     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2008.02.001     Document Type: Article

References (32)

1. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12 (1993) 39-85
2. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28 (2004) 405-440
3. Reid G., and Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4 (2002) 319-324
4. Casas I.A., and Dobrogosz W.J. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis 12 (2000) 257-285
5. Teitelbaum J.E. Probiotics and the treatment of infectious diarrhea. Pediatr Infect Dis J 24 (2005) 267-268
6. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006.
7. Caglar E., Kavaloglu Cildir S., Ergeneli S., Sandalli N., and Twetman S. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand 64 (2006) 314-318
8. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Moller P.L., Pedersen P., et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 21 (2002) 411-416
9. Axelsson L.T., Chung T.C., Dobrogosz W.J., and Lindgren S.E. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis 2 (1989) 131-136
10. Chung TC, Axelsson L, Lindgren E, Dobrogosz WJ. In vitro studies on reuterin synthesis by Lactobacillus reuteri, 1989. p. 137-44.
11. Yunmbam M.K., and Roberts J.F. In vivo evaluation of reuterin and its combinations with suramin, melarsoprol, DL-alpha-difluoromethylornithine and bleomycin in mice infected with Trypanosoma brucei brucei. Comp Biochem Physiol C 105 (1993) 521-524
12. Waters W.R., Harp J.A., Wannemuehler M.J., Carbajal N.Y., and Casas I.A. Effects of Lactobacillus reuteri on Cryptosporidium parvum infection of gnotobiotic TCR-alpha-deficient mice. J Eukaryot Microbiol 46 (1999) 60S-61S
13. Alak J.I., Wolf B.W., Mdurvwa E.G., Pimentel-Smith G.E., Kolavala S., Abdelrahman H., et al. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of Cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice. Cell Mol Biol (Noisy-le-grand) 45 (1999) 855-863
14. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Moller P.L., Tvede M., et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 21 (2002) 417-419
15. Talarico T.L., and Dobrogosz W.J. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother 33 (1989) 674-679
16. Doleyres Y., Beck P., Vollenweider S., and Lacroix C. Production of 3-hydroxypropionaldehyde using a two-step process with Lactobacillus reuteri. Appl Microbiol Biotechnol 68 (2005) 467-474
17. Luthi-Peng Q., Scharer S., and Puhan Z. Production and stability of 3-hydroxypropionaldehyde in Lactobacillus reuteri. Appl Microbiol Biotechnol 60 (2002) 73-80
18. Vollenweider S., Grassi G., Konig I., and Puhan Z. Purification and structural characterization of 3-hydroxypropionaldehyde and its derivatives. J Agric Food Chem 51 (2003) 3287-3293
19. Catassi C., Pierani P., Natalini G., Gabrielli O., Coppa G.V., and Giorgi P.L. Clinical application of a simple HPLC method for the sugar intestinal permeability test. J Pediatr Gastroenterol Nutr 12 (1991) 209-212
20. Talarico T.L., Casas I.A., Chung T.C., and Dobrogosz W.J. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother 32 (1988) 1854-1858
21. Circle S.J., Stone L., and Boruff C.S. Acrolein determination by means of tryptophane. A colorimetric method. Ind Eng Chem 17 (1945) 259-262
22. Schillinger U., and Lucke F.K. Antibacterial activity of Lactobacillus sake isolated from meat. Appl Environ Microbiol 55 (1989) 1901-1906
23. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Moller P.L., Michaelsen K.F., Paerregaard A., et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65 (1999) 4949-4956
24. Luthi-Peng Q., Dileme F.B., and Puhan Z. Effect of glucose on glycerol bioconversion by Lactobacillus reuteri. Appl Microbiol Biotechnol 59 (2002) 289-296
25. Holzapfel W.H., Haberer P., Snel J., Schillinger U., and Huis in't Veld J.H. Overview of gut flora and probiotics. Int J Food Microbiol 41 (1998) 85-101
26. Kabuki T., Saito T., Kawai Y., Uemura J., and Itoh T. Production, purification and characterization of reutericin 6, a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6. Int J Food Microbiol 34 (1997) 145-156
27. Ganzle M.G., Holtzel A., Walter J., Jung G., and Hammes W.P. Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol 66 (2000) 4325-4333
28. Ganzle M.G. Reutericyclin: biological activity, mode of action, and potential applications. Appl Microbiol Biotechnol 64 (2004) 326-332
29. Cleusix V., Lacroix C., Vollenweider S., Duboux M., and Le Blay G. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol 7 (2007) 101
30. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004:CD003048.
31. Savino F., Pelle E., Palumeri E., Oggero R., and Miniero R. Lactobacillus reuteri (American type culture collection strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119 (2007) e124-e130
32. Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A.W., et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 8 (2006) 1450-1454